Biogen Surges as Momentum for Alzheimer’s Treatment Revives Hope

(Bloomberg) -- Biogen Inc. will ask U.S. drug regulators to approve the company’s experimental Alzheimer’s therapy, reviving the nearly abandoned treatment after a new analysis of more data from tw...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.